Regenlab USA's IPO

Q: When is Regenlab USA's IPO?

Filed Sep 25, 2026 (Form S-1). No terms yet. Applied to list on Nasdaq.

Q: What is Regenlab USA's IPO price?

Regenlab USA has not set a price range yet; its Form S-1 of Sep 25, 2026 leaves it blank.

Q: When does the lock-up end?

Its prospectus sets a lock-up of 180 days; the day it ends is read from its final prospectus once it lists.

Filed Sep 25, 2026 (Form S-⁠1). No terms yet. Applied to list on Nasdaq.

Filed Sep 25 · Nasdaq · Form S-1

Breakaway does the work for you: insider and Congress trades, the chart, and the financials, in one score.

Once Regenlab USA lists, Breakaway scores it against every US stock

Its Quality Score from its second session, ranked against 3,191 stocks
Every insider trade, the day it is filed
The lock-up's end on your calendar, once the prospectus dates it
An alert when its score is first set, and when it turns

Get an alert the day Regenlab USA lists

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

From its Form S-1 on SEC EDGAR, filed Sep 25, 2026.

What does Regenlab USA do?

“RegenLab is the holder of over 70 granted patents, covering proprietary blood-processing devices (Platelet Rich Plasma, or "PRP"), crosslinked scaffolds, combination products (PRP with Hyaluronic Acid ("HA")), bone marrow-derived solutions, and bioengineered matrices designed for point-of-care preparation and safe, reproducible use across outpatient and surgical settings.”

From its Form S-1, filed Sep 25, 2026

Regenlab USA's facts, each with its source
Fact	Regenlab USA
Founded	2024From its Form S-1 of Sep 25, 2026
Headquarters	Jersey City, New JerseyFrom its Form S-1 of Sep 25, 2026
Website	regenlabusa.comFrom its Form S-1 of Sep 25, 2026

What is the offering?

Each figure names the filing it is from and that filing's date. The market cap is Breakaway's arithmetic from the prospectus's share count.

Regenlab USA's facts, each with its source
Fact	Regenlab USA
Exchange	NasdaqFrom the Form S-1 filed Sep 25, 2026

What the filing says about its money

Regenlab USA's facts, each with its source
Fact	Regenlab USA
Net loss	$1.2 million, year to December 31, 2025From its Form S-1 of Sep 25, 2026, its summary financial data
Cash	$4.8 million, as of June 30, 2026From its Form S-1 of Sep 25, 2026: cash and cash equivalents

What risks does Regenlab USA name first?

“The success of our business model depends on obtaining and maintaining regulatory approvals and clearances to market our products.”
“Even if we complete clinical testing and receive approval for a medical device, the FDA or other comparable regulatory authorities may grant approval or other marketing authorization contingent on the performance of costly additional clinical trials…”
“The successful continued commercialization of our products and any other product candidates will depend on obtaining reimbursement of our medical devices from third party payors.”

The first three of the risks its prospectus summary lists, in the company's words. The rest, and each in full, are in the filing. Read the filing.

Every date of Regenlab USA's IPO

Regenlab USA's IPO dates, each with its source
What	Day	Source
Registration filedForm S-1, SEC EDGAR	Sep 25, 2026	Form S-1, SEC EDGAR
Lock-upPer its Form S-1; the day comes once it lists	180 days	Per its Form S-1; the day comes once it lists

The other IPOs expected

The other IPOs expected or in registration
Company	Price	Market cap	Expected
OPAYNYSE: OPAY · No day yet	$19 to $21	Not yet	No day yetexchange registration Oct 26
Georgia BankingNasdaq: GBC · No day yet	Direct	Not yet	No day yetexchange registration Oct 21
Aspen NeuroscienceNasdaq: ASPE · No day yet	$15 to $17About $465M	$465Mat the midpoint	No day yetterms set Oct 26
Bambusa TherapeuticsNasdaq: BBTX · No day yet	$15 to $17About $796M	$796Mat the midpoint	No day yetterms set Oct 26
BitariNasdaq: BIAI · No day yet	$7About $302M	$302Mat the midpoint	No day yetterms set Oct 26
LIS TechnologiesNasdaq · No day yet	$5 to $7	Not yet	No day yetterms set Oct 26

Regenlab USA IPO questions

When is Regenlab USA's IPO?

Filed Sep 25, 2026 (Form S-⁠1). No terms yet. Applied to list on Nasdaq.

What is Regenlab USA's IPO price?

Regenlab USA has not set a price range yet; its Form S-⁠1 of Sep 25, 2026 leaves it blank.

When does the lock-up end?

Its prospectus sets a lock-⁠up of 180 days; the day it ends is read from its final prospectus once it lists.

Does Breakaway rate Regenlab USA?

Breakaway scores a new stock from its second trading day, ranked against every US stock it scores. For its first 21 sessions the page says New listing in place of the tier, and each check that needs more history waits for it.

Can Breakaway say where Regenlab USA's price will go?

No. Breakaway does not say where a price will go. Every figure here is from the company's SEC filings, linked on each line.

Where every figure comes from.

Each company's SEC filings on EDGAR, read twice a day: its registration (Form S-1 or F-1), the amendment that sets its price range, and its final prospectus (424B4). The shares, the price, the underwriters, the lock-up, and the company's words are the filing's, linked on each line.
The expected day is Massive's IPO calendar's, the first trade the market data's, and the moves each stock's daily closes against its offer price.
The market cap is Breakaway's arithmetic: the shares the prospectus says will be outstanding after the offering, times the midpoint of the range or the offer price.
The Quality Score is Breakaway's, from a stock's second trading day; for its first 21 sessions it is marked New listing, and each check that needs more history waits for it.
Blank-check companies (SPACs) and unit offerings are left out and counted; a direct listing and a US listing of a company listed abroad are in and marked.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Once Regenlab USA lists, Breakaway scores it against every US stock

Its Quality Score from its second session, ranked against 3,191 stocks
Every insider trade, the day it is filed
The lock-up's end on your calendar, once the prospectus dates it
An alert when its score is first set, and when it turns

Get an alert the day Regenlab USA lists

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Every IPO expected and listed.